8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-022266
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading xfor-20230613.htm…